Published in Cancer Res on December 15, 2006
Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv (2010) 1.68
Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells. J Am Chem Soc (2009) 1.67
Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J Control Release (2010) 1.54
Monolayer coated gold nanoparticles for delivery applications. Adv Drug Deliv Rev (2011) 1.36
Cancer therapies utilizing the camptothecins: a review of the in vivo literature. Mol Pharm (2010) 1.17
Superhydrophobic materials for tunable drug release: using displacement of air to control delivery rates. J Am Chem Soc (2012) 1.12
Polymeric nanoparticles for targeted treatment in oncology: current insights. Int J Nanomedicine (2015) 1.00
Multifunctional trackable dendritic scaffolds and delivery agents. Angew Chem Int Ed Engl (2011) 1.00
Anionic amphiphilic dendrimers as antibacterial agents. J Am Chem Soc (2008) 0.95
Hydrogels for osteochondral repair based on photocrosslinkable carbamate dendrimers. Biomacromolecules (2008) 0.92
Nitric oxide-releasing dendrimers as antibacterial agents. Biomacromolecules (2012) 0.92
Surface decorated gold nanoparticles by linear and cyclic peptides as molecular transporters. Mol Pharm (2013) 0.91
Influence of dendrimer surface charge on the bioactivity of 2-methoxyestradiol complexed with dendrimers. Soft Matter (2010) 0.85
Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions. AAPS PharmSciTech (2014) 0.84
Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry. Mol Pharm (2013) 0.84
Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics. Biomed Res Int (2014) 0.83
Non-Viral Delivery and Therapeutic Application of Small Interfering RNAs. Acta Naturae (2013) 0.83
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues. J Pharm Bioallied Sci (2014) 0.81
Triggered drug release from superhydrophobic meshes using high-intensity focused ultrasound. Adv Healthc Mater (2013) 0.80
Revolutionary impact of nanodrug delivery on neuroscience. Curr Neuropharmacol (2012) 0.79
Uptake, efflux, and mass transfer coefficient of fluorescent PAMAM dendrimers into pancreatic cancer cells. Biochim Biophys Acta (2012) 0.78
Dendritic Guanidines as Efficient Analogues of Cell Penetrating Peptides. Pharmaceuticals (Basel) (2010) 0.77
Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance. ACS Appl Mater Interfaces (2015) 0.77
Recent advances in glycerol polymers: chemistry and biomedical applications. Macromol Rapid Commun (2014) 0.76
The Influence of Pluronic F68 and F127 Nanocarrier on Physicochemical Properties, In vitro Release, and Antiproliferative Activity of Thymoquinone Drug. Pharmacognosy Res (2017) 0.75
Guest-Host Chemistry with Dendrimers-Binding of Carboxylates in Aqueous Solution. PLoS One (2015) 0.75
Advances in the application of nanotechnology in the diagnosis and treatment of gastrointestinal tumors. Mol Clin Oncol (2014) 0.75
In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer. J Nanobiotechnology (2016) 0.75
Oral absorption enhancement of probucol by PEGylated G5 PAMAM dendrimer modified nanoliposomes. Mol Pharm (2015) 0.75
Nanoencapsulation for drug delivery. EXCLI J (2014) 0.75
Carrier-free, self-assembled pure drug nanorods composed of 10-hydroxycamptothecin and chlorin e6 for combinatorial chemo-photodynamic antitumor therapy in vivo. Nanoscale (2017) 0.75
Discovery of anticancer agents of diverse natural origin. Pure Appl Chem (2009) 2.00
Multiple effects of silymarin on the hepatitis C virus lifecycle. Hepatology (2010) 1.92
Resorcylic acid lactones with cytotoxic and NF-κB inhibitory activities and their structure-activity relationships. J Nat Prod (2011) 1.81
Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies. Integr Cancer Ther (2007) 1.76
Effect of contrast agent charge on visualization of articular cartilage using computed tomography: exploiting electrostatic interactions for improved sensitivity. J Am Chem Soc (2009) 1.71
Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite. J Nat Prod (2011) 1.69
Identification of hepatoprotective flavonolignans from silymarin. Proc Natl Acad Sci U S A (2010) 1.67
Gram-scale purification of flavonolignan diastereoisomers from Silybum marianum (Milk Thistle) extract in support of preclinical in vivo studies for prostate cancer chemoprevention. Planta Med (2007) 1.61
Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. Cancer Res (2005) 1.61
New colchicinoids from a native Jordanian meadow saffron, colchicum brachyphyllum: isolation of the first naturally occurring dextrorotatory colchicinoid. J Nat Prod (2005) 1.59
Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum). Org Biomol Chem (2003) 1.58
Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma. J Antibiot (Tokyo) (2011) 1.52
HiFSA fingerprinting applied to isomers with near-identical NMR spectra: the silybin/isosilybin case. J Org Chem (2013) 1.52
X-ray-computed tomography contrast agents. Chem Rev (2012) 1.52
Photocrosslinkable hyaluronan as a scaffold for articular cartilage repair. Ann Biomed Eng (2004) 1.47
Expansile nanoparticles: synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system. J Am Chem Soc (2009) 1.46
Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection. Gastroenterology (2009) 1.40
Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release (2011) 1.39
Therapeutic and diagnostic applications of dendrimers for cancer treatment. Adv Drug Deliv Rev (2008) 1.35
Biomedical applications of dendrimers: a tutorial. Chem Soc Rev (2010) 1.28
Differential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and inflammation. PLoS One (2011) 1.27
Camptothecin and taxol: historic achievements in natural products research. J Nat Prod (2004) 1.26
ASHP statement on the use of dietary supplements. Am J Health Syst Pharm (2004) 1.26
Cytotoxic epipolythiodioxopiperazine alkaloids from filamentous fungi of the Bionectriaceae. J Antibiot (Tokyo) (2012) 1.24
DNA-PEG-DNA triblock macromolecules for reagentless DNA detection. J Am Chem Soc (2004) 1.23
Bioactive constituents of the stem bark of Mitrephora glabra. J Nat Prod (2009) 1.23
Charge-reversal amphiphiles for gene delivery. J Am Chem Soc (2004) 1.21
Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations. J Pharmacol Exp Ther (2009) 1.21
Cationic contrast agents improve quantification of glycosaminoglycan (GAG) content by contrast enhanced CT imaging of cartilage. J Orthop Res (2010) 1.18
Biologically responsive polymeric nanoparticles for drug delivery. Adv Mater (2012) 1.17
Dendritic macromers as in situ polymerizing biomaterials for securing cataract incisions. J Am Chem Soc (2004) 1.16
Cyclodepsipeptides, sesquiterpenoids, and other cytotoxic metabolites from the filamentous fungus Trichothecium sp. (MSX 51320). J Nat Prod (2011) 1.16
Clinical relevance of the small intestine as an organ of drug elimination: drug-fruit juice interactions. Expert Opin Drug Metab Toxicol (2007) 1.15
Benzoquinones and terphenyl compounds as phosphodiesterase-4B inhibitors from a fungus of the order Chaetothyriales (MSX 47445). J Nat Prod (2013) 1.15
Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells. Carcinogenesis (2007) 1.14
Hybrid dendritic-linear polyester-ethers for in situ photopolymerization. J Am Chem Soc (2002) 1.14
Biodendrimer-based hydrogel scaffolds for cartilage tissue repair. Biomacromolecules (2006) 1.13
High-resolution MS, MS/MS, and UV database of fungal secondary metabolites as a dereplication protocol for bioactive natural products. J Nat Prod (2013) 1.13
Prenylated benzophenones and xanthones from Hypericum scabrum. J Nat Prod (2004) 1.13
Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells. Int J Cancer (2008) 1.12
Synergistic antimicrobial activity of metabolites produced by a nonobligate bacterial predator. Antimicrob Agents Chemother (2003) 1.12
Superhydrophobic materials for tunable drug release: using displacement of air to control delivery rates. J Am Chem Soc (2012) 1.12
Tunable pores for measuring concentrations of synthetic and biological nanoparticle dispersions. Biosens Bioelectron (2011) 1.11
Chemical Diversity of Metabolites from Fungi, Cyanobacteria, and Plants Relative to FDA-Approved Anticancer Agents. ACS Med Chem Lett (2012) 1.11
Antioxidant activity and total phenolic content of aqueous and methanolic extracts of Jordanian plants: an ICBG project. Nat Prod Res (2007) 1.09
Use of the in vivo hollow fiber assay in natural products anticancer drug discovery. J Nat Prod (2009) 1.09
Antitumor agents. 228. five new agarofurans, Reissantins A-E, and cytotoxic principles from Reissantia buchananii. J Nat Prod (2003) 1.07
Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: comparison with silymarin and silibinin. Int J Cancer (2008) 1.07
Dendritic molecular capsules for hydrophobic compounds. J Am Chem Soc (2003) 1.07
Peptaibols from two unidentified fungi of the order Hypocreales with cytotoxic, antibiotic, and anthelmintic activities. J Pept Sci (2012) 1.06
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia. J Nat Prod (2004) 1.06
Contrast-enhanced CT with a high-affinity cationic contrast agent for imaging ex vivo bovine, intact ex vivo rabbit, and in vivo rabbit cartilage. Radiology (2012) 1.04
Greensporones: resorcylic acid lactones from an aquatic Halenospora sp. J Nat Prod (2014) 1.04
Silymarin for HCV infection. Antivir Ther (2012) 1.04
Identification of a cranberry juice product that inhibits enteric CYP3A-mediated first-pass metabolism in humans. Drug Metab Dispos (2008) 1.03
Antitumor agents. Part 214: synthesis and evaluation of curcumin analogues as cytotoxic agents. Bioorg Med Chem (2002) 1.02
Synthesis and properties of supramolecular ionic networks. J Am Chem Soc (2008) 1.02
Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport. Pharmacol Ther (2012) 1.01
Polyhydroxyanthraquinones as quorum sensing inhibitors from the guttates of Penicillium restrictum and their analysis by desorption electrospray ionization mass spectrometry. J Nat Prod (2014) 1.01
Conformationally gated electrochemical gene detection. Chembiochem (2004) 1.00
Supramolecular assemblies of nucleoside phosphocholine amphiphiles. J Am Chem Soc (2004) 1.00
Synthesis and aqueous aggregation properties of amphiphilic surface-block dendrimers. Org Lett (2005) 0.99
Peptaibols, tetramic acid derivatives, isocoumarins, and sesquiterpenes from a Bionectria sp. (MSX 47401). J Nat Prod (2013) 0.99
Prevention of in vivo lung tumor growth by prolonged local delivery of hydroxycamptothecin using poly(ester-carbonate)-collagen composites. J Control Release (2010) 0.99
Large-scale isolation of flavonolignans from Silybum marianum extract affords new minor constituents and preliminary structure-activity relationships. Planta Med (2009) 0.98